Work

Osteosarcoma metabolism-immune crosstalk: the metabolic-immune-vascular ecosystem and therapeutic vulnerabilities

Year: 2026
Type: article
Abstract: Osteosarcoma is one of the most common primary malignant bone tumors, and its high metastatic propensity, pronounced heterogeneity, and therapeutic resistance remain key determinants limiting long-term patient survival. Increasing evidence indicates that the malignant progression of osteosarcoma arises not only from intrinsic metabolic abnormalities of tumor cells but also from the dynamic interplay among metabolic reprogramming, immunosuppression, and aberrant angiogenesis within the tumor microenvironment. Osteosarcoma cells can enhance glycolysis and remodel lipid and amino acid metabolism to generate metabolic stresses such as lactate accumulation, nutrient competition, hypoxia, and redox imbalance. These changes not only support tumor cell survival and proliferation but may also influence the functional states of immune cells, including tumor-associated macrophages, T cells, NK cells, and myeloid-derived suppressor cells. At the same time, hypoxia and metabolic signals are closely related to aberrant angiogenesis, and dysfunctional tumor vasculature can further exacerbate hypoperfusion, immune cell exclusion, and metabolic adaptation. Together, these interactions constitute a dynamic metabolic-immune-vascular ecological network and may participate in osteosarcoma progression, lung metastasis, and therapeutic resistance. This article summarizes metabolic reprogramming in osteosarcoma and its interactions with the immune microenvironment and vascular niche, focusing on the therapeutic vulnerabilities that may arise from metabolic-immune-vascular crosstalk, and analyzes the research progress and limitations of combination strategies such as metabolic targeting, immune checkpoint blockade, engineered cell therapy, vascular normalization, and precision delivery. In addition, this article explores the application value of single-cell, spatial omics, and multi-omics technologies in dissecting metabolic–immune heterogeneity in osteosarcoma and identifying potentially intervenable niches. Given that some mechanisms are currently still mainly based on correlative evidence or other tumor models, future osteosarcoma-specific functional studies and clinical validation are still needed to clarify their causal relationships and translational value. A deeper understanding of this multidimensional microenvironmental network is expected to provide a theoretical basis for shifting osteosarcoma treatment from single-target intervention toward precision combination therapy based on biological vulnerabilities.
Language: English
Subfield: Cancer Research
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7226006650
FWCI:
Cites: 178
Cited by:
Related to: 9